Pfizer (NYSE: PFE)
Pfizer Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Pfizer Company Info
Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
News & Analysis
Is Pfizer Stock Going to $36? 1 Wall Street Analyst Thinks So.
The company's best days as a top pandemic vaccine supplier might be over, but it still has enough potential to be compelling.
Is Pfizer's 5.7% Dividend Yield Worth the Risk?
Pfizer's sky-high dividend yield is tempting, but is it sustainable?
Got $5,000? 3 Dirt Cheap Stocks to Buy Right Now
These stocks all trade at less than 14 times their expected future profits.
2 Beaten-Down Stocks That Could Be Great Buys on the Dip
They're down but not out, at least not yet.
A Few Years From Now, You'll Wish You Had Bought This Undervalued Stock
This big drugmaker's current challenges present an excellent buying opportunity for forward-thinking investors.
2 Incredibly Cheap Growth Stocks to Buy Now
The market has been tougher on these companies than some, but that could be a golden opportunity for the right investor.
3 Ways the Democratic Party's Platform Could Impact Biotech and Pharma Stocks if Implemented
There's no reason to succumb to gloom and doom here.
Is Pfizer Stock Still a Buy After an Unexpected Setback?
Its long-term growth plan just hit a small bump in the road.
Valuation
Podcast Episodes
A Coronavirus Vaccine Is Good News. What's Going on With Cruise Lines?
A look at stock market news.
Why Is a Coronavirus Vaccine Bad News for Some Stocks?
Investors knew that a vaccine was coming, so why did the market react the way it did?
Why Coronavirus Vaccine News Is Great for Bank Stocks and REITs
Some of our favorite banks and real estate stocks are having their best rallies in years.
2 Reasons Pfizer Is on Our Minds Today
First, it raised some spinoff speculation. Second, it's in an intriguing tussle with J&J that could affect the biosimilars market for everyone.
Earnings Transcripts
Pfizer (PFE) Q2 2024 Earnings Call Transcript
PFE earnings call for the period ending June 30, 2024.
Pfizer (PFE) Q1 2024 Earnings Call Transcript
PFE earnings call for the period ending March 31, 2024.
Pfizer (PFE) Q4 2023 Earnings Call Transcript
PFE earnings call for the period ending December 31, 2023.
Pfizer (PFE) Q3 2023 Earnings Call Transcript
PFE earnings call for the period ending September 30, 2023.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.